When asked on the social media platform for an update about the company, Mr. Musk replied, “Coming soon.” Previously, in September 2018, he said in an interview that Neuralink would be making an important announcement “in a few months.”
Neuralink’s mission is to augment human brains with computer technology via the implantation of tiny electrodes. In March, according to Bloomberg, five scientists associated with the company shared a paper online outlining what appears to be the preliminary research into this method; the paper is still unpublished, but may be the update to which Mr. Musk referred.
This type of brain-computer interface could be used for a multitude of purposes: as a non-invasive way to treat brain disease, to access an artificial intelligence-powered device with the mind or, in accordance with Mr. Musk’s previously expressed fears, to ensure humans remain smarter and more powerful than AI.
“Best-case scenario, we effectively merge with AI, where AI serves as a tertiary cognition layer. It will enable anyone who wants to have superhuman cognition,” he said in the September interview. “The merge scenario with AI is the one that seems like probably the best…If you can’t beat it, join it.”
More articles about AI:
UC San Diego unveils AI-powered tool to monitor runners’ heart rates, suggest optimal workouts
FDA approves AI-enabled wearable device for at-home vital sign tracking
AI startup streamlining electronic medical billing process receives investment from Northwestern Mutual
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.